An oral live attenuated vaccine strategy against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/2019-nCoV)

Madhusudana Girija Sanal; Ravi Chandra Dubey

doi:10.3897/rio.6.e53767

Related articles by

Research Idea

Research Ideas and Outcomes 6: e53767
https://doi.org/10.3897/rio.6.e53767 (13 May 2020)

Reviewed

Other versions:

(Verbatim name)

(Catalog Number)

DES

Invalid DOI was provided, please try again

(5)

(0)

Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, Shahid Bilal, Nauman Zafar, Aleena Siddique, Ayesha Zafar (2020)
New insights on possible vaccine development against SARS-CoV-2. Life Sciences 260: 118421.

DOI: 10.1016/j.lfs.2020.118421

Samagra Jain, Abhijeet Venkataraman, Marissa E. Wechsler, Nicholas A. Peppas (2021)
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic. Advanced Drug Delivery Reviews 179: 114000.

DOI: 10.1016/j.addr.2021.114000

Daniel Mietchen, Lyubomir Penev, Teodor Georgiev, Boriana Ovcharova, Iva Kostadinova (2021)
Open science in practice: 300 published research ideas and outcomes illustrate how RIO Journal facilitates engagement with the research process. Research Ideas and Outcomes 7: .

DOI: 10.3897/rio.7.e68595

Elena Alexander (2021)
Yeasts in nanotechnology-enabled oral vaccine and gene delivery. Bioengineered 12: 8325.

DOI: 10.1080/21655979.2021.1985816

Milankumar Patel, Farah Shahjin, Jacob D Cohen, Mahmudul Hasan, Jatin Machhi, Heerak Chugh, Snigdha Singh, Srijanee Das, Tanmay A Kulkarni, Jonathan Herskovitz, Douglas D Meigs, Ramesh Chandra, Kenneth S Hettie, R Lee Mosley, Bhavesh D Kevadiya, Howard E Gendelman (2021)
The Immunopathobiology of SARS-CoV-2 Infection. FEMS Microbiology Reviews 45: .

DOI: 10.1093/femsre/fuab035

Subscribe to email alerts for current Article's categories